ZYEPTI Trademark

Trademark Overview


On Tuesday, February 25, 2020, a trademark application was filed for ZYEPTI with the United States Patent and Trademark Office. The USPTO has given the ZYEPTI trademark a serial number of 79291195. The federal status of this trademark filing is REGISTERED as of Tuesday, August 3, 2021. This trademark is owned by H. Lundbeck A/S. The ZYEPTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and diso...
zyepti

General Information


Serial Number79291195
Word MarkZYEPTI
Filing DateTuesday, February 25, 2020
Status700 - REGISTERED
Status DateTuesday, August 3, 2021
Registration Number6436392
Registration DateTuesday, August 3, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements


Goods and ServicesPharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; Preparations, substances, reagents and agents for diagnostic and medical purposes, namely, for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions
Translation of Words in MarkThe wording "ZYEPTI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLundbeck Seattle BioPharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address 98011
US

Party NameLundbeck Seattle BioPharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address 98011
US

Party NameLundbeck Seattle BioPharmaceuticals Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
Address 98011
US

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDK

Trademark Events


Event DateEvent Description
Sunday, February 20, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 7, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 7, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 3, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 3, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 18, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Monday, May 17, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 28, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 25, 2021ASSIGNED TO LIE
Wednesday, March 24, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 15, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 15, 2021LETTER OF SUSPENSION E-MAILED
Monday, March 15, 2021SUSPENSION LETTER WRITTEN
Friday, February 26, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 25, 2021ASSIGNED TO LIE
Wednesday, November 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 9, 2020CHANGE OF OWNER RECEIVED FROM IB
Sunday, October 11, 2020REFUSAL PROCESSED BY IB
Wednesday, September 23, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 23, 2020REFUSAL PROCESSED BY MPU
Tuesday, August 18, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 18, 2020APPLICATION FILING RECEIPT MAILED
Monday, August 17, 2020NON-FINAL ACTION WRITTEN
Friday, August 14, 2020ASSIGNED TO EXAMINER
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 13, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB